Skandinaviska Enskilda Banken AB publ grew its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 12,078.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 19,851 shares of the company’s stock after acquiring an additional 19,688 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Henry Schein were worth $1,450,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Henry Schein in the 2nd quarter worth $43,000. Steph & Co. bought a new stake in Henry Schein during the second quarter valued at about $44,000. CX Institutional increased its position in Henry Schein by 107.3% in the second quarter. CX Institutional now owns 651 shares of the company’s stock worth $48,000 after buying an additional 337 shares in the last quarter. TD Private Client Wealth LLC raised its stake in shares of Henry Schein by 103.0% in the second quarter. TD Private Client Wealth LLC now owns 668 shares of the company’s stock worth $49,000 after buying an additional 339 shares during the period. Finally, Evelyn Partners Investment Management Services Ltd purchased a new position in shares of Henry Schein during the 2nd quarter valued at about $62,000. Institutional investors own 96.62% of the company’s stock.
Henry Schein Trading Down 2.0%
Shares of HSIC opened at $71.67 on Wednesday. The firm has a market cap of $8.44 billion, a P/E ratio of 23.12, a price-to-earnings-growth ratio of 2.06 and a beta of 0.84. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a 50 day simple moving average of $67.89 and a two-hundred day simple moving average of $69.41.
Analyst Ratings Changes
A number of brokerages recently issued reports on HSIC. Barrington Research set a $79.00 price objective on Henry Schein and gave the company an “outperform” rating in a research note on Wednesday, November 5th. Wells Fargo & Company upped their price target on shares of Henry Schein from $70.00 to $76.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 5th. Evercore ISI increased their price objective on shares of Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 5th. UBS Group decreased their price objective on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 6th. Finally, Wall Street Zen raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $76.08.
View Our Latest Stock Report on Henry Schein
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories
- Five stocks we like better than Henry Schein
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- Do ETFs Pay Dividends? What You Need to Know
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.
